Interactive simulation could change behaviors of those with type 2 diabetes

Cara Livernois | | Health Exec | Economics

An interactive, personalized simulation for patients with type 2 diabetes can show the effects of exercise on blood sugar, potentially improving behavior, according to a study published in JMIR Diabetes.

Led by Bryan Gibson, DPT, PhD, from the University of Utah in Salt Lake City, a team of researchers evaluated the effects a personalized and interactive simulation in 1,335 patients.

The participants completed seven tasks to measure baseline intentions and post-simulation outcome expectancy. Results showed an increase in intentions to increase the amount of walking done in the coming week.

"A novel interactive simulation is efficacious in changing the outcome expectancies and behavioral intentions of adults with T2DM," concluded Gibson and colleagues. "We discuss applications of our results to the design of mobile health interventions.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Cardiologist demand is on the rise—can hospitals keep up?
Cardinal Health scoops up two companies for $3.9B
UnitedHealth defends $3.3B Amedisys acquisition
DOJ sues to block UnitedHealth’s $3.3B acquisition of home health giant
Private equity firm to buy Summa Health for $485M
Private equity transactions in healthcare down 15% since 2023, report finds

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Design by Adaptive Theme
Trimed Popup
Trimed Popup